Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Caraci

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Current Drug Metabolism|March 15, 2011
Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extractFilippo Caraci, Rosalia Crupi, Filippo Drago, et al.
Annals of General Psychiatry|March 18, 2025
Can dextromethorphan-bupropion reduce mental pain in depressed individuals? A generating hypothesis overview perspectiveMaurizio Pompili, Isabella Berardelli, Denise Erbuto, et al.
CNS & Neurological Disorders Drug Targets|March 7, 2017
Clinically Relevant Drug Interactions with Anti-Alzheimer's DrugsFilippo Caraci, Janet Sultana, Filippo Drago, et al.
European Journal of Pharmacology|October 20, 2009
Depression and Alzheimer's disease: neurobiological links and common pharmacological targetsFilippo Caraci, Agata Copani, Ferdinando Nicoletti, et al.
European Journal of Pharmacology|November 23, 2017
Preface Drug discovery in neurodegenerative disorders: a defeat for pharmacology?Filippo Caraci, Aletta Kraneveld, Mojca Krzan, et al.
British Journal of Clinical Pharmacology|August 22, 2012
Epigenetic drugs for Alzheimer's disease: hopes and challengesFilippo Caraci, Gian Marco Leggio, Filippo Drago, et al.
Annals of General Psychiatry|October 11, 2023
Catatonia-like behavior and immune activation: a crosstalk between psychopathology and pathology in schizophreniaAntonino Messina, Filippo Caraci, Eugenio Aguglia, et al.
F1000Research|April 15, 2017
New drugs in psychiatry: focus on new pharmacological targetsFilippo Caraci, Gian Marco Leggio, Salvatore Salomone, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 17, 2010
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depressionSiegfried Kasper, Filippo Caraci, Bruno Forti, et al.
Folia Medica|February 14, 2024
Cell adhesion molecules in the pathogenesis of the schizophreniaAntonino Messina, Caterina Crescimanno, Giuseppe Cuccì, et al.
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Current Drug Metabolism|March 15, 2011
Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extractFilippo Caraci, Rosalia Crupi, Filippo Drago, et al.
Annals of General Psychiatry|March 18, 2025
Can dextromethorphan-bupropion reduce mental pain in depressed individuals? A generating hypothesis overview perspectiveMaurizio Pompili, Isabella Berardelli, Denise Erbuto, et al.
CNS & Neurological Disorders Drug Targets|March 7, 2017
Clinically Relevant Drug Interactions with Anti-Alzheimer's DrugsFilippo Caraci, Janet Sultana, Filippo Drago, et al.
European Journal of Pharmacology|October 20, 2009
Depression and Alzheimer's disease: neurobiological links and common pharmacological targetsFilippo Caraci, Agata Copani, Ferdinando Nicoletti, et al.
European Journal of Pharmacology|November 23, 2017
Preface Drug discovery in neurodegenerative disorders: a defeat for pharmacology?Filippo Caraci, Aletta Kraneveld, Mojca Krzan, et al.
British Journal of Clinical Pharmacology|August 22, 2012
Epigenetic drugs for Alzheimer's disease: hopes and challengesFilippo Caraci, Gian Marco Leggio, Filippo Drago, et al.
Annals of General Psychiatry|October 11, 2023
Catatonia-like behavior and immune activation: a crosstalk between psychopathology and pathology in schizophreniaAntonino Messina, Filippo Caraci, Eugenio Aguglia, et al.
F1000Research|April 15, 2017
New drugs in psychiatry: focus on new pharmacological targetsFilippo Caraci, Gian Marco Leggio, Salvatore Salomone, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 17, 2010
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depressionSiegfried Kasper, Filippo Caraci, Bruno Forti, et al.
Folia Medica|February 14, 2024
Cell adhesion molecules in the pathogenesis of the schizophreniaAntonino Messina, Caterina Crescimanno, Giuseppe Cuccì, et al.
Pageof 26